Objective To study the gene therapy of metastatic prostate cancer. Methods we investigated the ability of adenoviral vectors expressing cytokines IL-12 and IL-2 to induce regression of tumor in C57BL/6 mice models(n=66) of prostate cancer. Results Adenoviral vectors can express cytokines IL-12 and IL-2 proteins effectively. Only 20%(2/10) of mice inoculated with RM-1 cells engineered AdmIL-12 and AdhIL-2 developed smaller and delayed tumors ( P

Objective To investigate the expression level of MMP 1 and MMP 2 in the bladder transitional cell carcinoma (BTCC) and to analyse the location feature of expression and to provide a useful marker for judging the invasion. Methods From March 1998 to December 1999,62 cases of BTCC specimens were collected.The expression level of MMP 1 and MMP 2 of the specimens was detected by in situ hybridization technique. Results MMP 1 and MMP 2 were expressed in a small amount in the normal bladder walls.They were expressed mainly in cytoplasm of tumor cells and stromal cells. The positive rate of MMP 1 mRNA was 43.5%,and had no association with cell grade and TNM stage.The positive rate of MMP 2 mRNA was 59.6%.The expression level closely correlated with the cell grade and TNM stage ( P

The numbers of nucleolar organizer region (AgNOR) were counted by one-step silver colloid technique in 6 cases of normal bladder tissue, 9 chronic cystitis and 56 transitional cell carcinoma of bladder. The results revealed that the mean number of AgNOR per nucleus was not statistically different between normal bladder tissue and chronic cystitis while a significant difference was observed between normal, or inflammatory tissue and malignant tissue or between various grades of bladder tumor. The results also indicated that the mean number of AgNOR per nucleus was closely related to the prognosis of bladder tumor. So it is suggested that the AgNOR counting with silver stain technique may play a role in the differentiation of benign and malignant lesions and in the grading and prognosis of bladder tumors.

Genomic DNA from 17 primary human tcsticular seminomas was screend for the presence of mutations in exon 5 - 8 of P53 gene, using the single strand conformation polymorphism assay, followed by direct DNA sequencing. P53 mutations in one alle'e leading to an amino acid change were identified in 4 of 17 seminomas. Sites of mutations were in exon 5(codon 141), exon 7 (codon 238, codon 258) and exon 8(codon 279). The present study suggests that mutation of P53 gene is involved in the development of human testicular seminoma.

Objective To observe therapeutic effects of intravesical instillation of mitomycin C (MMC) immediately after TUR added with low dose BCG maintenance therapy to prevent recurrence of superficial bladder cancer. Methods 83 patients with superficial bladder cancer were randomly divided into two groups, 50 cases were managed with intravesical instillation of mitomycin C immediately after TUR added with low dose BCG maintenance therapy (group A), 33 cases were treated with traditional method of MMC therapy (group B) to prevent recurrence of superficial bladder cancer. Results After 12-66 months (mean 32 months) following up, 3 patients had tumor recurrence in the group A and 7 patients in the group B, the rate of tumor recurrence of the group A was 6.0% (3/50) and that of the group B was 21.2%(7/33), and there was a significantly difference between two groups (P<0.05). Side effects of the group B were obviously more than that of the group A. Conclusion Intravesical instillation of MMC immediately after TUR added with low dose BCG maintenance therapy is effective to prevent patients with superficial bladder cancer from recurrence.